CDB is everywhere these days. Products containing CBD can be purchased online, at health-food stores, and even at gas stations. The market for CBD containing or infused products is burgeoning and represents a lucrative opportunity for entrepreneurs as the market is expected to expand to a more than $16 billion industry by 2025. Despite its popularity, there is little in the way of regulation or guidance regarding the advertising and selling of CBD products.
In recent months, there have been a series of class-action lawsuits filed against the manufacturers and sellers of CBD products alleging false and misleading advertising and labeling of these products in violation of consumer protection statutes. In one of these newly filed class-action lawsuits, a putative class of consumers from Massachusetts filed a class-action lawsuit against Global Widget LLC, d/b/a Hemp Bombs (“Hemp Bombs”). The complaint alleges misleading labeling and statements concerning numerous Hemp Bombs products, including gummies, lollipops, capsules, syrup, vape and pet products.
According to the complaint, Cannabidiol (CBD) is a naturally occurring chemical compound known as a phytocannabinoid. CBD is typically derived from hemp plants for its purported medicinal qualities. CBD is used to treat anxiety, insomnia, depression, diabetes, PTSD, and chronic pain. CBD can be taken into the body in multiple ways, including by inhalation of smoke or vapor, as an aerosol spray into the cheek, and by mouth. Food and beverage items can be infused with CBD as an alternative means of ingesting the substance. Continue reading ›